United States · FDA National Drug Code directory

PredniSONE Tablets, USP, 20 mg

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72789-473_59965021-579f-f4e0-e063-6294a90a1b24
Product NDC
72789-473
Form
TABLET
Composition / generic term
PredniSONE
Labeler
PD-Rx Pharmaceuticals, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20250522
Source listing expiry
20271231

Source-listed ingredients

  • PREDNISONE — 20 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE, PLASTIC (72789-473-01) · 72789-473-01
  • 4 TABLET in 1 BOTTLE, PLASTIC (72789-473-04) · 72789-473-04
  • 5 TABLET in 1 BOTTLE, PLASTIC (72789-473-05) · 72789-473-05
  • 10 TABLET in 1 BOTTLE, PLASTIC (72789-473-10) · 72789-473-10
  • 14 TABLET in 1 BOTTLE, PLASTIC (72789-473-14) · 72789-473-14
  • 15 TABLET in 1 BOTTLE, PLASTIC (72789-473-15) · 72789-473-15
  • 18 TABLET in 1 BOTTLE, PLASTIC (72789-473-18) · 72789-473-18
  • 20 TABLET in 1 BOTTLE, PLASTIC (72789-473-20) · 72789-473-20
  • 21 TABLET in 1 BOTTLE, PLASTIC (72789-473-21) · 72789-473-21
  • 25 TABLET in 1 BOTTLE, PLASTIC (72789-473-25) · 72789-473-25
  • 30 TABLET in 1 BOTTLE, PLASTIC (72789-473-30) · 72789-473-30
  • 1000 TABLET in 1 BOTTLE, PLASTIC (72789-473-95) · 72789-473-95

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →